EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

DOT1L Epigenetically Regulates Autophagy and Mitochondria Fusion in Cell Lines of Renal Cancer

Yanguang Hou iD, Jiachen Liu, Shiyu Huang, Lei Wang, Juncheng Hu, Xiuheng Liu

Technology in Cancer Research & Treatment · 2023

DOI: 10.1177/15330338231167249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2023. Verfasst von Yanguang Hou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, key research and development program of Hubei Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

DOT1L, a histone methylase, is overexpression in renal cell cancer. However, the role and detailed molecular mechanism of DOT1L involved in renal cancer development remain unknown.

Methods

The inhibition of DOT1L was used by SGC0946 and short hairpin RNA silencing. Monodansylcadaverine staining and transmission electron microscope were performed to detect autophagy changes as a result of the inhibition of DOT1L. MitoTracker Red assay was used to analyze mitochondrial morphology. The autophagy markers and mitochondria-related proteins were analyzed by Western blot, qPCR, or immunofluorescence. ChIP assay was performed to demonstrate H3K79me2 is involved in the direct regulation of Farnesoid X receptor transcription.

Results

DOT1L inhibition increased autophagy activity and promoted mito chondria fusion in cell lines of renal cancer. Inhibition of DOT1L upregulated levels of LC3α/β, P62, MFN1, and MFN2, which contributed to autophagy activity or mitochondria fusion. DOT1L knockdown showed a similar the above process. DOT1L inhibition or silencing resulted in AMP-activated protein kinase activation and mammalian target of rapamycin inhibition. Mechanistically, the DOT1L inhibitor and its short hairpin RNAs decreased the expression of Farnesoid X receptor in a histone methylase-dependent manner.

Conclusion

We revealed the essential role of Farnesoid X receptor in regulating DOT1L-induced autophagy and mitochondrial fission through the AMP-activated protein kinase/mammalian target of rapamycin pathway in cell lines of renal cancer, which may provide new insights into the pathogenesis of renal cell cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansAMP-Activated Protein KinasesMitochondrial DynamicsCell LineHistone MethyltransferasesTOR Serine-Threonine KinasesAutophagyMitochondriaHistone-Lysine N-Methyltransferase

Stichwörter der Autor:innen

DOT1LFXRautophagymitochondria fusionrenal cancer

Substanzen

AMP-Activated Protein KinasesHistone MethyltransferasesTOR Serine-Threonine KinasesDOT1L protein, humanHistone-Lysine N-Methyltransferase

Autor:innen und Institutionen

  • Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.
  • Wuhan University Institute of Urologic Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.

ORCID-Profile: Yanguang Hou

Förderung

  • Fundamental Research Funds for the Central Universities
  • key research and development program of Hubei Province
  • National Natural Science Foundation of China

Zitieren

APA

Hou, Y., Liu, J., Huang, S., Wang, L., Hu, J., & Liu, X. (2023). DOT1L Epigenetically Regulates Autophagy and Mitochondria Fusion in Cell Lines of Renal Cancer. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338231167249

Vancouver

Hou Y, Liu J, Huang S, Wang L, Hu J, Liu X. DOT1L Epigenetically Regulates Autophagy and Mitochondria Fusion in Cell Lines of Renal Cancer. Technology in Cancer Research & Treatment. 2023. doi:10.1177/15330338231167249

BibTeX
@article{Hou2023,
  author = {Hou, Yanguang and Liu, Jiachen and Huang, Shiyu and Wang, Lei and Hu, Juncheng and Liu, Xiuheng},
  title = {DOT1L Epigenetically Regulates Autophagy and Mitochondria Fusion in Cell Lines of Renal Cancer},
  journal = {Technology in Cancer Research & Treatment},
  year = {2023},
  doi = {10.1177/15330338231167249}
}
Kostenlos starten →